Alvin (Al) Powers

February 20, 2026

Five honored at Translational Science and Research Forum

Translational research brings discoveries from the laboratory and preclinical studies forward to clinical trials and studies in humans.

September 30, 2025

Alvin Powers honored by Endocrine Society for his research in islet biology and diabetes

This award, which recognizes meritorious contributions to endocrinology research, is one of the Endocrine Society’s prestigious 2026 Laureate Awards.

Among those in Washington, D.C., were, from left, Nicholas Warren, Shelagh Mulvaney, PhD, Alvin Powers, MD, Patrick Hu, MD, PhD, Hyun Song, PhD, Ronald McMillan, PhD, and Sara Kavanaugh.
September 25, 2025

Vanderbilt scientists advocate for NIH funding in Congress

Scientists from Vanderbilt University Medical Center and Vanderbilt University joined other advocates from Tennessee to share why continued bipartisan support for NIH is important to them.

February 24, 2025

Leadership announced for Division of Diabetes, Endocrinology and Metabolism

An interim plan has been announced to fill the roles held by Alvin C. Powers, MD, in Vanderbilt’s Division of Diabetes, Endocrinology and Metabolism.

Terri Doss, second from right, a research assistant at the Vanderbilt Mouse Metabolic Phenotyping Center, received the Robert K. Hall Service Award for her outstanding contributions to the diabetes research community. Young investigators receiving awards at Diabetes Day are, left to right, Kathryn Snyder, MD, MPH; Darian Carroll; Doss and Dudley McNitt, PhD. Not pictured is Emily Hawes, PhD. (photo by Susan Urmy)
June 6, 2024

Diabetes Day spotlights achievements, current investigations

Today, the Vanderbilt Diabetes Research and Training Center includes 140 faculty members from 15 departments and three colleges or schools at Vanderbilt and Meharry Medical College who conduct basic, clinical and translational research on the cause, prevention, treatment and complications of diabetes and obesity.

February 2, 2024

Study links small pancreas size to faster progression to stage 3 Type 1 diabetes

The study findings, published in the journal Diabetes Care, suggest that pancreas imaging can have a benefit in tracking disease development and recruitment for preventive and therapeutic trials.